146 related articles for article (PubMed ID: 33063251)
1. Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion.
Nicolson NG; Paulsson JO; Juhlin CC; Carling T; Korah R
Endocr Pathol; 2020 Dec; 31(4):367-376. PubMed ID: 33063251
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma.
Leong D; Gill AJ; Turchini J; Waller M; Clifton-Bligh R; Glover A; Sywak M; Sidhu S
World J Surg; 2023 Feb; 47(2):412-420. PubMed ID: 36031639
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.
Nicolson NG; Murtha TD; Dong W; Paulsson JO; Choi J; Barbieri AL; Brown TC; Kunstman JW; Larsson C; Prasad ML; Korah R; Lifton RP; Juhlin CC; Carling T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2640-2650. PubMed ID: 29726952
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of widely invasive and minimally invasive follicular thyroid carcinoma with sonography.
Shin JH; Han BK; Ko EY; Oh YL; Kim JH
Eur J Radiol; 2010 Jun; 74(3):453-7. PubMed ID: 19369019
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Distant Metastasis in Patients with Minimally Invasive Follicular Thyroid Carcinoma.
Lee YM; Song DE; Kim TY; Sung TY; Yoon JH; Chung KW; Hong SJ
PLoS One; 2016; 11(5):e0155489. PubMed ID: 27171147
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of minimally invasive follicular carcinomas by gene profiling.
Lubitz CC; Gallagher LA; Finley DJ; Zhu B; Fahey TJ
Surgery; 2005 Dec; 138(6):1042-8; discussion 1048-9. PubMed ID: 16360389
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
Wu J; Zhang Y; Cheng R; Gong W; Ding T; Zhai Q; Wang Y; Meng B; Sun B
Histopathology; 2019 Apr; 74(5):780-791. PubMed ID: 30368884
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
9. An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms.
Cracolici V; Parilla M; Henriksen KJ; Cipriani NA
Head Neck Pathol; 2020 Jun; 14(2):399-405. PubMed ID: 31218593
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for follicular thyroid carcinoma: the importance of vascular invasion.
Ito Y; Hirokawa M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A; Miyauchi A
Endocr J; 2022 Sep; 69(9):1149-1156. PubMed ID: 35491160
[TBL] [Abstract][Full Text] [Related]
12. Mutation profiles of follicular thyroid tumors by targeted sequencing.
Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).
Dionigi G; Kraimps JL; Schmid KW; Hermann M; Sheu-Grabellus SY; De Wailly P; Beaulieu A; Tanda ML; Sessa F
Langenbecks Arch Surg; 2014 Feb; 399(2):165-84. PubMed ID: 24233345
[TBL] [Abstract][Full Text] [Related]
14. Follicular thyroid carcinoma: histology and prognosis.
D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
West J; Munoz-Antonia T; Johnson JG; Klotch D; Muro-Cacho CA
Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134
[TBL] [Abstract][Full Text] [Related]
16. Immunoexpression of TTF-1 and Ki-67 in a coexistent anaplastic and follicular thyroid cancer with rare long-life surviving.
Ziad el A; Ruchala M; Breborowicz J; Gembicki M; Sowinski J; Grzymislawski M
Folia Histochem Cytobiol; 2008; 46(4):461-4. PubMed ID: 19141399
[TBL] [Abstract][Full Text] [Related]
17. ID Proteins May Reduce Aggressiveness of Thyroid Tumors.
Amaral LHP; Bufalo NE; Peres KC; Barreto IS; Campos AHJFM; Ward LS
Endocr Pathol; 2019 Mar; 30(1):24-30. PubMed ID: 30413933
[TBL] [Abstract][Full Text] [Related]
18. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
19. Utility of Tumor Capsule Thickness as a Predictor of Invasion in Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and a Diagnostic Tool for Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features.
French B; Hattier G; Mardekian SK
Int J Surg Pathol; 2020 Feb; 28(1):13-19. PubMed ID: 31256687
[No Abstract] [Full Text] [Related]
20. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
